Bartlett & Co Wealth Management’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-33
Closed -$97 1268
2024
Q4
$97 Hold
33
﹤0.01% 1110
2024
Q3
$156 Hold
33
﹤0.01% 1109
2024
Q2
$127 Hold
33
﹤0.01% 1119
2024
Q1
$177 Hold
33
﹤0.01% 1106
2023
Q4
$151 Hold
33
﹤0.01% 1220
2023
Q3
$129 Hold
33
﹤0.01% 1157
2023
Q2
$334 Hold
33
﹤0.01% 1125
2023
Q1
$337 Hold
33
﹤0.01% 1039
2022
Q4
$309 Hold
33
﹤0.01% 1078
2022
Q3
$480 Hold
33
﹤0.01% 1148
2022
Q2
$436 Hold
33
﹤0.01% 1272
2022
Q1
$563 Buy
+33
New +$560 ﹤0.01% 1044

Other funds holding TSVT

Bartlett & Co Wealth Management's TSVT Position: Q1 2025 in Review

Bartlett & Co Wealth Management sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 33 shares — an estimated $97 sold.

Bartlett & Co Wealth Management first reported a position in TSVT in Q1 2022 and held it in 12 quarters. The position peaked at $563 in Q1 2022. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Bartlett & Co Wealth Management reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 33 2seventy bio shares in Q1 2025, an estimated $97.
  • Bartlett & Co Wealth Management first reported a position in 2seventy bio in Q1 2022 and held it in 12 quarters.
  • Bartlett & Co Wealth Management's 2seventy bio position peaked at $563 in Q1 2022.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.